WCG IPO Presentation Deck

5 WCG Mission: To Reduce Time and Cost of Clinical Trials Discovery & Development Early Drug Discovery -56% of Total Time -29% of Total Cost Pre-Clinical Research IND 1 I 1 1 1 1 Phase I Trial Clinical Trials Sources: 2019 Tufts center for the study of drug development Published in Journal of Health Economics IND = Investigational New Drug application, which provides approval for human clinical trials to start. NDA= New Drug Application, which provides approval for sale and marketing. Phase II Trial -44% of Total Time: -71% of Total Cost: Phase III Trial + Approval NDA Up to 10-15 Years Up to $2.6bn Post-Approval Phase IV DN L wcg WCG Mission: To Reduce Time & Cost of Clinical Trials wcg By Offering Solutions to Address the Critical Pain Points I

View entire presentation